Literature DB >> 23657761

Effectiveness and Duration of Effect of Open-Label Lisdexamfetamine Dimesylate in Adults With ADHD.

Lenard A Adler1,2, Lauren R Lynch3, David M Shaw1, Samantha P Wallace4, Katherine E O'Donnell1, Michael A Ciranni5, Alexis M Briggie6, Stephen V Faraone7.   

Abstract

OBJECTIVES: (a) Evaluate the efficacy and duration of effect of lisdexamfetamine dimesylate (LDX) in adult ADHD. (b) Assess the reliability and validity of the Adult ADHD Medication Smoothness of Effect Scale (AMSES) and Adult ADHD Medication Rebound Scale (AMRS).
METHOD: Adults ( N = 40) with ADHD were treated with LDX for up to 12 weeks. The primary efficacy measure was the ADHD Rating Scale (ADHD-RS). The psychometric properties of the AMSES and AMRS are analyzed and compared with the ADHD-RS, ADHD Self-Report Scale (ASRS) v1.1 Symptom Checklist, and Time-Sensitive ADHD Symptom Scale (TASS).
RESULTS: ADHD-RS scores were significantly improved with LDX. The AMSES and AMRS had high internal consistency and were correlated with the ADHD-RS, ASRS v1.1 Symptom Checklist, and TASS.
CONCLUSION: LDX is effective in treating adult ADHD and has a smooth drug effect throughout the day with limited symptom rebound. The AMSES and AMRS are valid and reliable measures.

Entities:  

Keywords:  ADHD; LDX; adult ADHD treatment

Mesh:

Substances:

Year:  2016        PMID: 23657761     DOI: 10.1177/1087054713485421

Source DB:  PubMed          Journal:  J Atten Disord        ISSN: 1087-0547            Impact factor:   3.256


  5 in total

1.  Personalized Treatment of Mothers With ADHD and Their Young At-Risk Children: A SMART Pilot.

Authors:  Andrea Chronis-Tuscano; Christine H Wang; Jennifer Strickland; Daniel Almirall; Mark A Stein
Journal:  J Clin Child Adolesc Psychol       Date:  2016-01-22

2.  Neural Correlates of Symptom Improvement Following Stimulant Treatment in Adults with Attention-Deficit/Hyperactivity Disorder.

Authors:  Zhen Yang; Clare Kelly; Francisco X Castellanos; Terry Leon; Michael P Milham; Lenard A Adler
Journal:  J Child Adolesc Psychopharmacol       Date:  2016-03-30       Impact factor: 2.576

3.  Update on optimal use of lisdexamfetamine in the treatment of ADHD.

Authors:  Vishal Madaan; Venkata Kolli; Durga P Bestha; Manan J Shah
Journal:  Neuropsychiatr Dis Treat       Date:  2013-07-22       Impact factor: 2.570

4.  The effects of sleep deprivation on the processing of emotional facial expressions in young adults with and without ADHD.

Authors:  Orrie Dan; Iris Haimov; Ami Cohen; Kfir Asraf; Ivgeny Saveliev
Journal:  Sci Rep       Date:  2021-07-09       Impact factor: 4.379

Review 5.  Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder.

Authors:  Jadwiga Najib; Dexter Wimer; Julie Zeng; Kristina W Lam; Natalya Romanyak; Eva Paige Morgan; Anu Thadavila
Journal:  J Cent Nerv Syst Dis       Date:  2017-08-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.